Ahrnsbrak et al., “Key substance
use and mental health indicators in the United States: Results from the 2016
National Survey on Drug Use and Health,” Substance Abuse and Mental Health
Services Administration, September 2017.
Bureau of Health Workforce, Health
Resources and Services Administration (HRSA), U.S. Department of Health &
Human Services, [Designated Health Professional Shortage Areas Statistics:
Designated HPSA Quarterly Summary, as of December 31, 2017] (https://ersrs.hrsa.gov/ReportServer?/HGDW_Reports/BCD_HPSA/BCD_HPSA_SCR50_Qtr_Smry_HTML&rc:Toolbar=false).
Kessler et al., “Lifetime
prevalence and age-of-onset distributions of DSM-IV disorders in the National
Comorbidity Survey Replication,” Archives of General Psychiatry, 2005 Jun;
Cloutier et al., “The economic
burden of schizophrenia in the United States in 2013,” Journal of Clinical
Psychiatry, 2016 Jun;77(6):764-71.
“Depression: Key Facts.” World
Health Organization, 22 March 2018.
Kessler et al., “Individual and
societal effects of mental disorders on earnings in the United States: results
from the National Comorbidity Survey Replication,” American Journal of
Psychiatry, 2008 Jun;165(6):703-11.
Owens et al., “Mental health and
substance abuse-related emergency department visits among adults, 2007,” Agency
for Healthcare Research and Quality, Healthcare Cost and Utilization Project,
Steadman et al., “Prevalence of
serious mental illness among jail inmates,” Psychiatric Services, 2009 Jun;60(6):761-65.
Stone et al., “Vital signs: trends
in state suicide rates – United States, 1999-2016 and circumstances
contributing to suicide – 27 states, 2015,” Morbidity and Mortality Weekly Report, 2018 Jun;
67(22):617-24.Available at https://www.cdc.gov/mmwr/volumes/67/wr/mm6722a1.htm